.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Teva
Harvard Business School
Julphar
Cerilliant
McKesson
US Army
Argus Health
AstraZeneca
Farmers Insurance

Generated: November 22, 2017

DrugPatentWatch Database Preview

TOLBUTAMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Tolbutamide, and what generic Tolbutamide alternatives are available?

Tolbutamide is a drug marketed by Watson Labs, Barr, Dava Pharms Inc, Alra, Ascot, Mylan Pharms Inc, Parke Davis, Purepac Pharm, Sandoz, Vangard, Ivax Pharms, and Superpharm. and is included in sixteen NDAs.

The generic ingredient in TOLBUTAMIDE is tolbutamide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tolbutamide profile page.

Pharmacology for TOLBUTAMIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

Medical Subject Heading (MeSH) Categories for TOLBUTAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086109-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alra
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086141-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL087318-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086574-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ascot
TOLBUTAMIDE
tolbutamide
TABLET;ORAL087541-001Mar 1, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Superpharm
TOLBUTAMIDE
tolbutamide
TABLET;ORAL088893-001Nov 19, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
TOLBUTAMIDE
tolbutamide
TABLET;ORAL012678-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL089110-001May 29, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TOLBUTAMIDE
tolbutamide
TABLET;ORAL089111-001May 29, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086926-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Moodys
Novartis
McKesson
Mallinckrodt
Deloitte
AstraZeneca
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot